Forskning
Udskriv Udskriv
Switch language
Bispebjerg Hospital - en del af Københavns Universitetshospital
Udgivet

The effect of remote ischaemic preconditioning on myocardial injury in emergency hip fracture surgery (PIXIE trial): phase II randomised clinical trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Association between use of macrolides in pregnancy and risk of major birth defects: nationwide, register based cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Laparoscopic versus robot assisted repair of ventral hernia

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  3. Quality of dietary fat and genetic risk of type 2 diabetes: individual participant data meta-analysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Dairy consumption, systolic blood pressure, and risk of hypertension: Mendelian randomization study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Waking Up in Pain: a prospective unselected cohort study of pain in 3702 patients immediately after surgery in the Danish Realm

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Agreement Between Transcutaneous Monitoring and Arterial Blood Gases During COPD Exacerbation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Live video from bystanders' smartphones to improve cardiopulmonary resuscitation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Live video from bystanders' smartphones to medical dispatchers in real emergencies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Sarah Ekeloef
  • Morten Homilius
  • Maiken Stilling
  • Peter Ekeloef
  • Seda Koyuncu
  • Anna-Marie Bloch Münster
  • Christian S Meyhoff
  • Ossian Gundel
  • Julie Holst-Knudsen
  • Ole Mathiesen
  • Ismail Gögenur
Vis graf over relationer

OBJECTIVE: To investigate whether remote ischaemic preconditioning (RIPC) prevents myocardial injury in patients undergoing hip fracture surgery.

DESIGN: Phase II, multicentre, randomised, observer blinded, clinical trial.

SETTING: Three Danish university hospitals, 2015-17.

PARTICIPANTS: 648 patients with cardiovascular risk factors undergoing hip fracture surgery. 286 patients were assigned to RIPC and 287 were assigned to standard practice (control group).

INTERVENTION: The RIPC procedure was initiated before surgery with a tourniquet applied to the upper arm and consisted of four cycles of forearm ischaemia for five minutes followed by reperfusion for five minutes.

MAIN OUTCOME MEASURES: The original primary outcome was myocardial injury within four days of surgery, defined as a peak plasma cardiac troponin I concentration of 45 ng/L or more caused by ischaemia. The revised primary outcome was myocardial injury within four days of surgery, defined as a peak plasma cardiac troponin I concentration of 45 ng/L or more or high sensitive troponin I greater than 24 ng/L (the primary outcome was changed owing to availability of testing). Secondary outcomes were peak plasma troponin I and total troponin I release during the first four days after surgery (cardiac and high sensitive troponin I), perioperative myocardial infarction, major adverse cardiovascular events, and all cause mortality within 30 days of surgery, length of postoperative stay, and length of stay in the intensive care unit. Several planned secondary outcomes will be reported elsewhere.

RESULTS: 573 of the 648 randomised patients were included in the intention-to-treat analysis (mean age 79 (SD 10) years; 399 (70%) women). The primary outcome occurred in 25 of 168 (15%) patients in the RIPC group and 45 of 158 (28%) in the control group (odds ratio 0.44, 95% confidence interval 0.25 to 0.76; P=0.003). The revised primary outcome occurred in 57 of 286 patients (20%) in the RIPC group and 90 of 287 (31%) in the control group (0.55, 0.37 to 0.80; P=0.002). Myocardial infarction occurred in 10 patients (3%) in the RIPC group and 21 patients (7%) in the control group (0.46, 0.21 to 0.99; P=0.04). Statistical power was insufficient to draw firm conclusions on differences between groups for the other clinical secondary outcomes (major adverse cardiovascular events, 30 day all cause mortality, length of postoperative stay, and length of stay in the intensive care unit).

CONCLUSIONS: RIPC reduced the risk of myocardial injury and infarction after emergency hip fracture surgery. It cannot be concluded that RIPC overall prevents major adverse cardiovascular events after surgery. The findings support larger scale clinical trials to assess longer term clinical outcomes and mortality.

TRIAL REGISTRATION: ClinicalTrials.gov NCT02344797.

OriginalsprogEngelsk
TidsskriftBMJ
Vol/bind367
Sider (fra-til)l6395
ISSN1756-1833
DOI
StatusUdgivet - 4 dec. 2019

Bibliografisk note

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

ID: 58951468